Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
8 papers
Recent·Most cited
V. Lemmens, L. Kelchtermans, S. Debaveye, W. Chiu, T. Vercruysse, J. Ma, H. J. Thibaut, J. Neyts, L. Sanchez-Felipe, K. Dallmeier
This study develops a dual-target vaccine against Ebola and yellow fever viruses, showing it protects mice against both pathogens with a single dose.
bioRxiv · Jan 13, 2023 · PreprintImmunology
L.-H. Li, L. Liesenborghs, L. Wang, M. Lox, M. B. Yakass, S. Jansen, A. L. Rosales Rosas, X. Zhang, H. J. Thibaut, D. Teuwen, J. Neyts, L. Delang, K. Dallmeier
This study evaluates the safety and biodistribution of a YF17D-vectored SARS-CoV-2 vaccine candidate in hamsters, showing improved safety compared to parental YF17D.
bioRxiv · Jan 24, 2022Microbiology
M. Imbrechts, W. Kerstens, M. Rasulova, T. Vercruysse, W. Maes, L. Ampofo, K. Ven, J. Lammertyn, K. Vanhoorelbeke, N. Callewaert, J. Neyts, K. Dallmeier, P. Declerck, H. J. Thibaut, N. Geukens
The paper evaluates a panel of anti-SARS-CoV-2 monoclonal antibodies for neutralizing activity against SARS-CoV-2 delta and omicron variants, finding three mAbs retain activity, with mAb 3B8 showing potent neutralization against both.
bioRxiv · Dec 21, 2021 · PreprintImmunology
M. Rasulova, T. Vercruysse, J. Paulissen, C. Coun, V. Suin, L. Heyndrickx, J. Ma, K. Geerts, J. Timmermans, N. Mishra, L.-H. Li, D. B. Kum, L. Coelmont, S. Van Gucht, H. Karimzadeh, , H. J. Thibaut
This paper develops a high-throughput fluorescence-based assay (SNTFLUO) for detecting yellow fever neutralizing antibodies, validated against WHO standards and applicable for differential diagnostics.
bioRxiv · Dec 16, 2021 · PreprintMicrobiology
M. Imbrechts, W. Maes, L. Ampofo, N. Van den Berghe, B. Calcoen, D. Van Looveren, S. Noppen, K. Hollevoet, T. Vercruysse, X. Zhang, R. Abdelnabi, C. S.-Y. Foo, H. J. Thibaut, D. Jochmans, K. Ven, , N. Geukens
The paper identifies potent anti-SARS-CoV-2 mAbs that cure infection in hamsters and demonstrates gene-based delivery for in vivo protection against variants.
bioRxiv · Nov 25, 2021Immunology
S. Sharma, T. Vercruysse, L. Sanchez-Felipe, W. Kerstens, P. Maes, R. Abdelnabi, C. S. Foo, V. Lemmens, D. Van Looveren, G. Baele, B. Weynand, P. Lemey, J. Neyts, H. J. Thibaut, K. Dallmeier
This study shows an updated vaccine candidate provides full protection against multiple SARS-CoV-2 variants, prevents transmission, and induces neutralizing antibodies against Omicron in hamsters.
bioRxiv · Nov 12, 2021 · PreprintMicrobiology
S. J. Kaptein, S. Jacobs, L. Langendries, L. Seldeslachts, S. ter Horst, L. Liesenborghs, B. Hens, V. Vergote, E. Heylen, E. Maas, C. De Keyzer, L. Bervoets, J. Rymenants, T. Van Buyten, H. J. Thibaut, , L. Delang
This study evaluates the antiviral effects of favipiravir and hydroxychloroquine in SARS-CoV-2-infected hamsters, finding limited efficacy for both drugs.
bioRxiv · Jun 19, 2020 · PreprintMicrobiology
R. Boudewijns, H. J. Thibaut, S. J. F. Kaptein, R. Li, V. Vergote, L. Seldeslachts, C. De Keyzer, L. Bervoets, S. Sharma, J. Van Weyenbergh, L. Liesenborghs, J. Ma, S. Jansen, D. Van Looveren, T. Vercruysse, , X. Saelens
This study shows that STAT2 signaling both restricts SARS-CoV-2 spread and causes severe pneumonia in infected hamsters.
bioRxiv · Apr 23, 2020 · PreprintMicrobiology